- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
CMS Offers Guidance on EHR Incentive Appeals
Hospitals and clinicians that have failed to obtain payments through the government's Medicare electronic health-record system incentive program and those seeking to challenge a payment amount now can look to the CMS for guidance on the appeals process.
The appeals deadline for hospitals has been extended from Dec. 31, 2011, to Jan. 30, 2012, according to the site.
The CMS has contracted with Provider Resources of Erie, Pa., to work with the agency's Office of Clinical Standards and Quality "to provide customer service support and technical assistance" to providers seeking an appeal of a decision involving the EHR incentive program, which was created under the American Recovery and Reinvestment Act of 2009.
Source: Modern Healthcare
Appeals decisions will be posted at OCSQ Appeals beginning in February.
Administrative-appeals information is available for download from the CMS' website for hospitals and healthcare professionals that have been deemed ineligible to participate in the program or denied meaningful-user status. Information also is available about payment calculation appeals.
Streamlining "Brain-to-Vein" Time, Patient Selection, Imperative for Implementing CAR T for MM
March 21st 2025Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Overcoming CAR T Manufacturing Failure in LBCL
March 21st 2025Data incorporated for this study were collected from 9 centers in the UK focused on third-line and beyond chimeric antigen receptor (CAR) T-cell administration in patients with relapsed/refractory large B-cell lymphoma (LBCL).
Read More
